Drugs that contain Ranitidine Bismuth Citrate
1. Tritec patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5456925 | GLAXOSMITHKLINE | Pharmaceutical compositions containing furan derivatives |
Oct, 2012
(11 years ago) | |
| US5601848 | GLAXOSMITHKLINE | Methods for the treatment of gastrointestinal disorders |
Feb, 2014
(10 years ago) | |
| US5629297 | GLAXOSMITHKLINE | Medicament for treating gastrointestinal disorders |
May, 2014
(9 years ago) | |
Market Authorisation Date: 08 August, 1996
Treatment: Method of treating peptic ulcer disease caused by campylobacter pyloridis comprising oral administration of 50 to 5,000mg bismuth daily for 3-56 days; Method for treating gi disorders caused by h. pyl...
Dosage: TABLET;ORAL
More Information on Dosage
TRITEC family patents
